The themes Alcon is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
매출 비중은 FY2025 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.
UNITY VCS and UNITY CS
Equipment systems used for retinal and cataract surgery. They help surgeons remove eye tissue or a cloudy natural lens and replace it.
PanOptix Pro
An artificial lens implanted during cataract surgery, designed to help patients see at near, middle and far distances.
Hydrus Microstent
A small device implanted during cataract surgery to help fluid drain from the eye and lower pressure in some people with glaucoma.
DAILIES TOTAL1
A daily disposable contact lens designed with a high-water-content surface for comfort.
Systane
Eye drops that temporarily relieve burning and irritation associated with dry eye.
TRYPTYR
Prescription eye drops for dry eye disease that stimulate natural tear production.
Alcon makes equipment and disposable supplies used in cataract, retinal, laser-vision and glaucoma surgery, as well as artificial lenses implanted during cataract operations. It also sells daily and reusable contact lenses and eye drops for dry eye, allergies, glaucoma and contact-lens care. Hospitals and surgery centers buy surgical products, while eye-care practices, retailers, pharmacies and distributors sell or prescribe its vision-care products.
Alcon Inc.이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.
US$71.84-0.8%11월 12일 종가
2026년 9월 30일까지의 수치 (2026년 11월 10일 제출 6-K 기준)
Alcon sells eye-surgery equipment and implants to hospitals and surgeons, and contact lenses and eye medicines to consumers through eye-care professionals and retailers.
Grade A
주가 아래 띠는 각 날짜의 등급으로, 그 시점까지 공개된 자료만으로 산출했습니다.
Alcon Inc.의 등급 이력 26개 분기 중 2개를 표시하고 있습니다. 나머지 24개는 2020년 2월까지 거슬러 올라갑니다.